22nd Century Group (22nd Century Group) Valuation Rank

View and export this data going back to 2011. Start your Free Trial

What is 22nd Century Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

22nd Century Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

22nd Century Group (22nd Century Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204

Website

https://www.xxiicentury.com

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.

Executives

Andrew Arno	director	C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish	director, officer: Chief Executive Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino	officer: Chief Administrative Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola	officer: Chief Legal Officer	BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller	officer: President, Tobacco	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany	director	C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher	officer: Chief Operating Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman	officer: Chief Financial Officer	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald	officer: Chief Financial Officer	C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson	director	C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders	director	1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien	director	C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov	director	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan	director	C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203